510(k) K792019

PHADECODE XA INHIBITOR ASSAY by Pharmaseal Div., Baxter Healthcare Corp. — Product Code JBQ

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
November 5, 1979
Date Received
October 9, 1979
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antithrombin Iii Quantitation
Device Class
Class II
Regulation Number
864.7060
Review Panel
HE
Submission Type